Scripps Translational Science Institute

By Heather Mack 03:17 pm December 21, 2016
Nature Research has teamed up with Scripps Translational Science Institute to launch a new international journal that will focus on digital health, the organizations announced this week. The journal, npj Digital Medicine, is under the Nature Partner Journal series and will publish original papers and review articles that aim to guide innovation in health tied to digital and mobile technologies...
By Jonah Comstock 01:57 pm July 7, 2016
The National Institutes of Health announced a number of partners today who will receive a total of $55 million in grant money for 2016 to build the foundational structures of the White House's Precision Medicine Initiative (PMI). The PMI Cohort Program includes five companies that make up the Participant Technologies Center, which will be responsible for creating mobile apps to enroll, consent,...
By Jonah Comstock 04:03 pm May 18, 2016
Aliso Viego, California-based Sentrian's remote patient monitoring program has been in a pilot with COPD patients at Anthem subsidiary CareMore for about six months, Sentrian founder and Chief Medical Officer Jack Kriendler told attendees at the American Telemedicine Association conference in Minneapolis this week. The results are encouraging. [Ed note: To learn more about CareMore's remote...
By Brian Dolan 01:53 pm January 20, 2016
News broke earlier this week that Scripps Translational Science Institute’s Wired For Health study showed the digital health monitoring used in the randomized control trial of 160 patients had no impact on outcomes or the cost of care during the first six months. The results were met with a mix of reactions from people working in healthcare who shared their thoughts on Twitter. Some chalked it up...
By Jonah Comstock 04:31 pm January 19, 2016
The results are in for the Scripps Translational Science Institute’s Wired For Health study, and there’s no sugar-coating it: they’re disappointing for those working in digital health. The six-month randomized control trial found no short-term benefit in health costs or outcomes for patients monitoring their health with connected devices.  “It was a bit disappointing, but remember, this was the...
By Jonah Comstock 10:55 am November 30, 2015
The Scripps Translational Science Institute is working with Aetna and Johnson & Johnson to launch a trial that will test iRhythm's Zio Patch and the Amiigo activity tracker as possible new ways to screen at-risk populations for atrial fibrillation. "What we really want at the end of this study is to be able to best understand what the right way is to screen high-risk patients for atrial...
By Jonah Comstock 05:47 am May 5, 2015
Mountain View, California-based Amiigo, which makes an activity tracker that raised $580,000 on Indiegogo in 2013, has teamed up with online patient community platform Alliance Health to launch a new study looking at the combined effect of wearables and peer support on heart failure patients. “There are a lot of different questions we can begin to ask related to the value of a social networking...
By Jonah Comstock 10:16 am May 4, 2015
Aliso Viego, California-based Sentrian, the remote patient monitoring company formerly known as Jointly Health, will work with Scripps Translational Science Institute to study its technology on 2,000 patients with COPD. All the patients are members of CareMore, an Anthem subsidiary that focuses on elderly patients and connected care. The Sentrian Remote Patient Intelligence platform uses...
By Aditi Pai 09:31 am February 12, 2015
Sotera Wireless's ViSi Mobile monitor. The Scripps Translational Science Institute (STSI) has received a grant from the US Agency for International Development (USAID) to create a program that will use health sensors to improve the health outcomes of Ebola patients. The program is called STAMP2, short for Sensor Technology and Analytics to Monitor, Predict and Protect Ebola Patients. STSI...
By Aditi Pai 08:24 am August 19, 2014
Tokyo-based Atonarp raised $8 million in a round led by Walden Riverwood Ventures to further develop the company's smart spectrometer. Atonarp is developing a spectrometer that can non-invasively detect early phase cancer detection and it also has designed on non-invasive blood glucose measurement. To detect cancer, the company's device analyzes a user's breath. Atonarp's website notes that...